Company intelligence / Profile preview

Degge Group

Ownership: Private
Employees: ~1
Development stage: Commercial

Overview

The Degge Group specialized in consulting services for the biopharmaceutical and medical products sector, focusing on clinical drug safety, pharmacovigilance, pharmacoepidemiology research, risk evaluation and mitigation strategies[1][2][3][5].

It was acquired by PharmaLex GmbH[5].

No clinical results or pipeline as it did not develop drugs.

Industry: Consulting

Partnerships

Not specified; likely worked with various pharmaceutical companies as clients[6]

Beyond the preview

Go deeper on Degge Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Degge Group.

Explore the full profile